04.10.2021 -
US drugs giant Merck & Co. has signed a definitive agreement to acquire publicly traded US biotech Acceleron Pharma for $180 per share, yielding a total equity value of...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)